Finding 480882 (2021-005)

Significant Deficiency Repeat Finding
Requirement
I
Questioned Costs
-
Year
2021
Accepted
2024-08-09

AI Summary

  • Core Issue: AAPT did not consistently follow procurement policies, leading to inadequate documentation of bids and selection processes.
  • Impacted Requirements: Compliance with 2 CFR 200.317-326, which mandates cost or price analysis for all procurement actions.
  • Recommended Follow-Up: Ensure all procurement records include selection justification and document compliance; management to update policies and enforce adherence by April 15, 2024.

Finding Text

Finding 2021-005: Procurement Federal Programs: Research and Development Cluster: All Grants Criteria or Specific Requirement (Including Statutory, Regulatory, or Other Citation): Procedures articulated in 2 CFR 200.317-326, requires that for all procurement of goods and services, some form of cost or price analysis shall be made and documented in the procurement files in connection with every procurement action based on the dollar thresholds sited in the compliance code. Condition: AAPT did not consistently adhere to written policies with respect to the procurement process, as bids/quotes were not obtainable or the conclusion for selection was not documented. Cause: AAPT’s internal policies and procedures governing procurement were not consistently applied. Effect or Potential Effect: Without proper and complete procurement documentation, there is a risk that AAPT will not perform proper evaluation of each element of cost to determine reasonableness. Questioned Costs: None noted. Context: Our audit procedures consisted of internal control testwork over the cash disbursement cycle over a sample population of expenditures. We consider our sample to be representative of the population. The condition appeared to be systematic in nature. Identification as a Repeat Finding, if Applicable: 2020-005. Recommendation: We recommend that all procurement records for purchases in excess of the purchase threshold include the following, at a minimum: (a) basis for contractor/goods selection or (b) justification for lack of competition when competitive bids or offers are not obtained. Additionally, the conclusion should be clearly documented and accompanying the procurement documentation. Views of Responsible Officials and Planned Corrective Actions: Management will update current policies and procedures and review and enforce the polices. Management will be responsible for proper documentation and confirmation that all policies and procedures are followed. Management will confirm that all agreements, mou’s and contracts are property, reviewed signed and documented. Management will require all departments to document all procurements for goods and services with written cost and price analysis based on AAPT's dollar thresholds. Anticipated Completion Date: 04/15/2024 Responsible Official: Dr. Beth Cunningham CEO, Michael Brosnan CFO

Categories

Procurement, Suspension & Debarment

Other Findings in this Audit

  • 480849 2021-003
    Material Weakness Repeat
  • 480850 2021-005
    Significant Deficiency Repeat
  • 480851 2021-003
    Material Weakness Repeat
  • 480852 2021-005
    Significant Deficiency Repeat
  • 480853 2021-003
    Material Weakness Repeat
  • 480854 2021-005
    Significant Deficiency Repeat
  • 480855 2021-003
    Material Weakness Repeat
  • 480856 2021-004
    Significant Deficiency Repeat
  • 480857 2021-005
    Significant Deficiency Repeat
  • 480858 2021-003
    Material Weakness Repeat
  • 480859 2021-005
    Significant Deficiency Repeat
  • 480860 2021-006
    Significant Deficiency Repeat
  • 480861 2021-003
    Material Weakness Repeat
  • 480862 2021-005
    Significant Deficiency Repeat
  • 480863 2021-003
    Material Weakness Repeat
  • 480864 2021-004
    Significant Deficiency Repeat
  • 480865 2021-005
    Significant Deficiency Repeat
  • 480866 2021-003
    Material Weakness Repeat
  • 480867 2021-005
    Significant Deficiency Repeat
  • 480868 2021-003
    Material Weakness Repeat
  • 480869 2021-005
    Significant Deficiency Repeat
  • 480870 2021-003
    Material Weakness Repeat
  • 480871 2021-005
    Significant Deficiency Repeat
  • 480872 2021-003
    Material Weakness Repeat
  • 480873 2021-005
    Significant Deficiency Repeat
  • 480874 2021-003
    Material Weakness Repeat
  • 480875 2021-005
    Significant Deficiency Repeat
  • 480876 2021-003
    Material Weakness Repeat
  • 480877 2021-005
    Significant Deficiency Repeat
  • 480878 2021-005
    Significant Deficiency Repeat
  • 480879 2021-005
    Significant Deficiency Repeat
  • 480880 2021-003
    Material Weakness Repeat
  • 480881 2021-005
    Significant Deficiency Repeat
  • 1057291 2021-003
    Material Weakness Repeat
  • 1057292 2021-005
    Significant Deficiency Repeat
  • 1057293 2021-003
    Material Weakness Repeat
  • 1057294 2021-005
    Significant Deficiency Repeat
  • 1057295 2021-003
    Material Weakness Repeat
  • 1057296 2021-005
    Significant Deficiency Repeat
  • 1057297 2021-003
    Material Weakness Repeat
  • 1057298 2021-004
    Significant Deficiency Repeat
  • 1057299 2021-005
    Significant Deficiency Repeat
  • 1057300 2021-003
    Material Weakness Repeat
  • 1057301 2021-005
    Significant Deficiency Repeat
  • 1057302 2021-006
    Significant Deficiency Repeat
  • 1057303 2021-003
    Material Weakness Repeat
  • 1057304 2021-005
    Significant Deficiency Repeat
  • 1057305 2021-003
    Material Weakness Repeat
  • 1057306 2021-004
    Significant Deficiency Repeat
  • 1057307 2021-005
    Significant Deficiency Repeat
  • 1057308 2021-003
    Material Weakness Repeat
  • 1057309 2021-005
    Significant Deficiency Repeat
  • 1057310 2021-003
    Material Weakness Repeat
  • 1057311 2021-005
    Significant Deficiency Repeat
  • 1057312 2021-003
    Material Weakness Repeat
  • 1057313 2021-005
    Significant Deficiency Repeat
  • 1057314 2021-003
    Material Weakness Repeat
  • 1057315 2021-005
    Significant Deficiency Repeat
  • 1057316 2021-003
    Material Weakness Repeat
  • 1057317 2021-005
    Significant Deficiency Repeat
  • 1057318 2021-003
    Material Weakness Repeat
  • 1057319 2021-005
    Significant Deficiency Repeat
  • 1057320 2021-005
    Significant Deficiency Repeat
  • 1057321 2021-005
    Significant Deficiency Repeat
  • 1057322 2021-003
    Material Weakness Repeat
  • 1057323 2021-005
    Significant Deficiency Repeat
  • 1057324 2021-005
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
43.001 Science $41,592
47.049 Mathematical and Physical Sciences $23,501
47.076 Education and Human Resources $20,896